Here are three points:
1. CEO Peter Crosby will present at the conference held on Jan. 11, 2017.
2. Mainstay Medical is in the process of bringing ReActiv8 to market.
3. ReActiv8 is an implantable neurostimulation system for patients with chronic low back pain.
More articles on devices:
SpineGuard hits FY 2016 revenue of $7.95M — 5 key notes
Implanet receives 21st patent for JAZZ technology: 4 key points
Mazor Robotics receives record-high 62 system orders in FY 2016 — 7 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
